Navigation Links
ScinoPharm to Invest in Tanvex Biologics

ScinoPharm to Invest in Tanvex Biologics -- TAINAN, Taiwan, Aug. 31 /PRNewswire-Asia/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Acquisitions, Mergers and Takeovers Click to view news release full screen  

ScinoPharm to Invest in Tanvex Biologics


TAINAN, Taiwan, Aug. 31 /PRNewswire-Asia/ -- ScinoPharm, a leading active pharmaceutical ingredient (API) developer and manufacturer headquartered in Taiwan, today announced an investment into Tanvex Biologics, Inc., a United States company registered in the State of Delaware. ScinoPharm's investment was in the form of tangible assets, intellectual properties, as well as cash.

Tanvex specializes in the development of biosimilars and biobetters, as well as the provision of contract research and contract manufacturing services for biologics. The company is currently establishing a cGMP facility in San Diego, California and will have research centers in both the U.S. and Taiwan. Tanvex is founded by Dr. Allen Chao, the founder and former Chairman and Chief Executive Officer of Watson Pharmaceuticals, Inc.

Dr. Hardy Chan, co-founder and Chief Scientific Officer of ScinoPharm, will become the Chief Executive Officer of Tanvex. Dr. Chao will remain as Executive Chairman of Tanvex.

About ScinoPharm Taiwan

ScinoPharm Taiwan, Ltd. is a leading process R&D and API manufacturing service provider to the global pharmaceutical industry. With research and manufacturing facilities in both Taiwan and mainland China, ScinoPharm offers a wide portfolio of services ranging from custom synthesis for early phase pharmaceutical activities to brand companies as well as APIs for the generic industry. For more information, please visit .

About Tanvex Biologics

Tanvex Biologics, LLC is a US-based biopharmaceutical company specializing in the development of biopharmaceuticals.

Media Contact: ScinoPharm Taiwan, Ltd. Sabrian Wu Tel: +886-6-505-2869 Mobile Phone: +886-920-056-385 Email:

SOURCE ScinoPharm Taiwan, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson Signs Agreement to Divest Equity Interest in ScinoPharm
2. ScinoPharm Announces SafeBridge Potent Compound Safety Certification
3. Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference
4. Zimmer Holdings to Present at INVESTIndiana Equity Conference
5. Hill-Rom to Present at the INVESTIndiana Investor Conference
6. Curemark to Present at the Rodman & Renshaw Annual Global Investment Conference
7. JumpStart Ventures Invests In and Provides Entrepreneurial Assistance to Drug Development Company
8. Advanced Life Sciences Featured as Special Stock Pick by KonLin Investment Letter
9. Sangon & Bio Basic Inc. Closes $10 Million Round of Investment by Qiming Ventures
10. Water Street Healthcare Partners Announces New Investment in Medical Specialties Distributors, LLC
11. AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
Post Your Comments:
(Date:12/1/2015)... VERONA, Virginia , 1 de diciembre ... líder en tecnología para cuchillas de precisión, ... un programa de identidad de marca. El ... en el diseño y la ingeniería de ... toda la diferencia". ...
(Date:12/1/2015)... , Dec. 1, 2015 During the ... San Francisco, CA , Medinol ... the coronary marketplace. During a satellite symposium, "The ... Design to Minimize Restenosis", a renowned physician panel ... Medinol NIRxcell™ CoCr Coronary Stent System and the ...
(Date:12/1/2015)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... that the company will present at the LD Micro Main ... Luxe Sunset Boulevard Hotel in Los Angeles, CA. ... will present on Thursday, December 3, at 9:00 am Pacific ... register at least 10 minutes prior to the start of ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 2015 , ... According to an article published on November 16th ... the U.S. Department of Health and Human Services, claiming that any states which do ... the clause in the law prohibiting the denial of coverage for pre-existing conditions. The ...
(Date:12/1/2015)... ... ... Dr. Paul Vitenas, one of the top cosmetic surgeons in Texas ... Best Single Physician Practice in the nation. Dr. Vitenas and his practice were named ... industry publication. , Dr. Vitenas said he was very honored to receive such ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... have seen vast improvements in scientific research and discoveries, leading us to better ... hope and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform edition of “World ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... the United States. Podiatrists are well aware that psychology-based patient non-compliance (disobedience of ... often catastrophic contributors to diseases of the diabetic foot. The American Board ...
(Date:12/1/2015)... ... 01, 2015 , ... Visage accelerates mobile imaging results access ... of Pro Medicus Ltd. (ASX: PME), has announced they are demonstrating new work-in-progress ... (RSNA) 2015 annual meeting through December 3 in Chicago, Illinois, at Booth #1350, ...
Breaking Medicine News(10 mins):